The association of vitamin B12 and folate blood levels with mortality and cardiovascular morbidity incidence in the old old: The Bronx Aging Study

American Journal of Therapeutics

Volumn 4, Issue 7-8, 1997, Pages 275-281

  Zeitlin, Anna ^a   Frishman, William H ^a,b   Chang, Chee Jen ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Cardiovascular morbidity; Folate; Homocysteine; Risk factor; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROKE; UNITED STATES; VITAMIN BLOOD LEVEL;

EID: 0030812224     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199707000-00008     Document Type: Article

References (21)

1. Mayer EL, Jacobsen DW, Robinson K: Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996;27: 517-527.
2. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al.: Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324: 1149-1154.
3. Duell PB, Malinow MR: Homocyteine: an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol 1997;8:28-34.
4. Boers GHJ, Smals AGH, Trijbels FJM, Fowler B, Bakkeran JAJM, Schoonderwaldt HC, et al.: Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985;313: 709-715.
5. Rees MM, Rodgers GM: Homocyteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993;71:337-359.
6. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, et al.: Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-291.
7. Dalery K, Lussier-Cacan S, Selhub J, Davignon J, Latour Y, Genest J Jr: Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate. Am J Cardiol 1995;75:1107-1111.
8. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a, risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-1057.
9. Den Heijer M, Koster T, Blom HJ, Bos GMJ, Briet E, Reitsma PH, et al.: Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334: 759-762.
10. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM: Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 1993;13: 1327-1333.
11. Stampfer MJ, Malinow MR: Can lowering homocysteine levels reduce cardiovascular risks? N Engl J Med 1995; 332:328-329.
12. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-2698.
13. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, et al.: Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 1995; 92:2825-2830.
14. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RCP, Alvarez JO, et al.: Plasma homocyst(e)ine, folate and vitamin B12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 1994;59:940-948.
15. Crystal HA, Ortof E, Frishman WH, Gruber A, Hershman D, Aronson M: Serum B12 levels and incidence of dementia in healthy elderly population: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 1994;42:993-936.
16. Zimetbaum P, Frishman WH, Ooi WL, Derman MP, Aronson M, Gidez LI, et al.: Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. Arterioscler Thromb 1992;12:416-423.
17. Hershman DL, Simonoff PA, Frishman WH, Paston F, Aronson M: Drug utilization in the old old and how it relates to self-perceived health and all-cause mortality. Results from the Bronx Aging Study. J Am Geriatr Soc 1995;43:356-360.
18. McLaren DS: The luxus vitamins - A and B12. Am J Clin Nutr 1981;34:1611-1616.
19. Brattstrom L, Israelson B, Lindgarde F, Hultberg B: Higher total plasma homocysteine in vitamin B12 deficiency than heterozygosity for homocysteinuria due to cystathionone B-synthase deficiency. Metabolism 1988; 37:175-178.
20. Brattstrom L, Hultberg BL, Hardebo JE: Folic acid responsive postmenopausal homocysteinemia. Metabolism 1985;34:1073-1077.
21. Brattstrom LE, Israelsson B, Jeppson JO, Hultberg B: Folic acid - an innocuous means to reduce plasma homocysteine. Scand J Clin Invest 1988;48:215-221.